The European Commission approved Kimberly-Clark's $48.7 billion purchase of Kenvue on Tuesday, October 13, after the Texas-based group agreed to divest its European feminine hygiene brands to preserve price competition in the segment.

The clearance removes the last major regulatory obstacle to a deal that pulls together two of the largest consumer portfolios on both sides of the Atlantic. Kimberly-Clark brings Huggies, Kleenex and Kotex. Kenvue adds Neutrogena, Aveeno, Johnson's Baby and OGX to the combined shelf.

For formulators and procurement teams, the transaction concentrates a substantial share of mass-market skincare and personal care under one owner. Neutrogena and Aveeno alone give the merged group two of the most widely stocked dermocosmetic brands in European pharmacy and drug channels, while OGX anchors its salon-adjacent haircare position.

What did the Commission require?

The EU's concern centred on feminine hygiene. Kimberly-Clark's Kotex overlaps directly with Kenvue's portfolio in several European markets, and regulators concluded that the merged entity could have raised prices or reduced choice for consumers. The commitment to divest the European feminine hygiene business resolved those concerns.

The Commission framed the remedy in terms of affordability: the divestment keeps the affected brands competitive and available at accessible price points. This condition mirrors the Commission's recent practice of demanding structural remedies rather than behavioural pledges in concentrated consumer categories.

What does this change for the beauty and personal care supply chain?

Three practical consequences follow for industry professionals:

• Portfolio consolidation. Brand owners competing against Neutrogena and Aveeno now face a single counterparty with deeper marketing and distribution resources across mass, pharmacy and e-commerce channels.
• Procurement leverage. Suppliers of actives, packaging and contract manufacturing may see contract consolidation as the combined group rationalises its vendor base across skincare, baby care and haircare.
• Divestment opportunity. The European feminine hygiene brands put up for sale will attract private equity and mid-cap strategics, creating a new owner with its own reformulation and repackaging needs.

The deal also signals where the market is heading. Consumer health and personal care groups increasingly treat scale as the answer to private-label pressure and retailer bargaining power. A combined Kimberly-Clark-Kenvue entity spans diapers, tissues, sun care, cleansers and haircare — a breadth few competitors can match.

What comes next?

The divestment process now moves to execution. A buyer must be found and approved for the European feminine hygiene business, and the speed of that sale will determine when Kimberly-Clark can complete integration. Watch the announcement of the divestiture buyer and the first post-merger portfolio decisions from the combined group as the next concrete data points.